Forty drugs accounted for 71% of Medicare spending for drugs administered in physician and hospital outpatient settings last year, according to a dashboard released this week by the Centers for Medicare & Medicaid Services. Five of the drugs accounted for more than $1 billion each in Part B spending, CMS said. The dashboard looks at Part B and D drugs with the highest cost, cost increase or spending per user in 2014. The largest increase in average cost per unit was more than 500%. “The drugs included in the dashboard are likely to have an impact on spending and should spur public discussion of how these products are affecting the Medicare program,” wrote CMS Acting Administrator Andy Slavitt and Chief Data Officer Niall Brennan. Comments and feedback on the dashboard may be sent to druglistinput@cms.hhs.gov. CMS plans to release similar data for Medicaid next year.

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for…
Headline
Twenty-three organizations, including the AHA, Friday urged the Centers for Medicare & Medicaid Services to suspend implementation of new draft Medicare…
Headline
More than 880,000 physicians were certified by the American Board of Medical Specialties in 2017, about 20,000 more than in 2016, according to the board’…